Author
Marilyn R. London
Bio: Marilyn R. London is an academic researcher from Rhode Island Hospital. The author has contributed to research in topics: Population & End stage renal disease. The author has an hindex of 2, co-authored 3 publications receiving 121 citations.
Papers
More filters
TL;DR: Long-term patency of access was evaluated in 76 patients, without diabetes mellitus, who had been on dialysis for at least 3 years and 41 patients, with diabetes mell Titus, whoHad been ondialysis for over 2 years, finding fistulas functioned longer than grafts and declotting or revision of restored graft function was ineffective.
Abstract: Complications associated with vascular accesses account for approximately 30% of hospital admissions for chronic hemodialysis patients. Long-term patency of access was evaluated in 76 patients, without diabetes mellitus, who had been on dialysis for at least 3 years and 41 patients, with diabetes mellitus, who had been on dialysis for over 2 years. Fistulas functioned longer than grafts (58 vs. 22 months, p
107 citations
TL;DR: It appears from the data that the DRGs do not adequately reflect the cost of caring for ESRD patients with the same DRGs as non-ESRD patients because of increased demand for ancillary services.
14 citations
TL;DR: The presence of renal osteodystrophy and medical artifacts associated with the treatment of kidney failure in human remains may provide information about the individual's medical history, and evidence of rare disease may be useful in the identification of unknown remains.
Cited by
More filters
TL;DR: Large differences in vascular access use exist between EUR and the US, even after adjustment for patient characteristics, and the results strongly suggest that a facility's preferences and approaches to vascular access practice are major determinants of vascularAccess use.
820 citations
TL;DR: Type of initial hemodialysis access was associated with 1-year mortality in the US Medicare dialysis population and Mortality risks were fistulae, grafts, and catheters.
327 citations
TL;DR: Results show that the upper-arm native arteriovenous fistula (UAF) is a good alternative to an AVG for achieving Dialysis Outcomes Quality Initiative guidelines.
269 citations
TL;DR: A program for early placement of A-V fistulae, a continuous quality improvement, multidisciplinary program to monitor access outcome, the development of new biomaterials, and a research plan to investigate pharmacological intervention to reduce development of stenosis and clinical interventions to treat those that do develop, prior to thrombosis are proposed.
267 citations
TL;DR: The patency rate for PTFEs is similar to that for AVFs, but AVFs require fewer revisions, and AVFs have excellent patency rates and PDCs have excellentPatency rates, but failure rates are doubled in patients with diabetes.
264 citations